New Product Watch


Affymetrix has launched its Axiom myDesign Targeted Genotyping Arrays to enable researchers to study mutations in disease pathways and characterize gene-gene interactions.

Customers can now design arrays to genotype between 1,500 and 2.6 million markers per sample, allowing them to move from genome-wide scans to specific disease analyses with different experimental approaches on the same platform, according to the firm. Users can create their own arrays using Affy's Axiom Design Center online tool.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.